BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Liming Wang, Weihu Wang, Xuesong Yao, Weiqi Rong, Fan Wu, Bo Chen, Mei Liu, Shengtao Lin, Yunhe Liu, Jianxiong Wu. Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasionOncotarget 2017; 8(45): 79971 doi: 10.18632/oncotarget.20402
2
T. Mocan, Z. Sparchez, R. Craciun, C. N. Bora, D. C. Leucuta. Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectivesClinical and Translational Oncology 2019; 21(6): 702 doi: 10.1007/s12094-018-1975-4
3
Jian-Hong Zhong, Ning-Fu Peng, Xue-Mei You, Liang Ma, Xiao Xiang, Yan-Yan Wang, Wen-Feng Gong, Fei-Xiang Wu, Bang-De Xiang, Le-Qun Li. Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world studyOncotarget 2017; 8(11): 18296 doi: 10.18632/oncotarget.15433
4
Chao He, Wei Peng, Chuan Li, Tian-Fu Wen. Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resectionMedicine 2017; 96(16): e6606 doi: 10.1097/MD.0000000000006606
5
Sarah J. M. Hale, Richard D. Perrins, Cristina Espinosa Garcı́a, Alessandro Pace, Usoa Peral, Ketan R. Patel, Angela Robinson, Phil Williams, Yao Ding, Gabriele Saito, Miguel Ángel Rodriguez, Ibon Perera, Africa Barrientos, Kelly Conlon, Steve Damment, John Porter, Tom Coulter. DM1 Loaded Ultrasmall Gold Nanoparticles Display Significant Efficacy and Improved Tolerability in Murine Models of Hepatocellular CarcinomaBioconjugate Chemistry 2019; 30(3): 703 doi: 10.1021/acs.bioconjchem.8b00873